Diabetes and depression: Global perspectives

Diabetes Research and Clinical Practice

Volumn 87, Issue 3, 2010, Pages 302-312

  Egede, Leonard E ^a,b   Ellis, Charles ^b,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Depression; Diabetes; Global perspective; Health care; Health outcomes

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; NORTRIPTYLINE;

9 ITEM PATIENT HEALTH QUESTIONNAIRE; ATTITUDE TO ILLNESS; CLINICAL TRIAL; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIABETES MELLITUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR DEPRESSION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREVALENCE; PRODUCTIVITY; PSYCHOMETRY; QUALITY OF LIFE; REVIEW; SCREENING TEST; SELF CARE; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

COMORBIDITY; DEPRESSIVE DISORDER; DIABETES MELLITUS; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; LIFE STYLE; QUALITY OF HEALTH CARE; QUALITY OF LIFE; SELF CARE; WORLD HEALTH;

EID: 77649190271     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.01.024     Document Type: Review

References (85)

1. International Diabetes Federation. Diabetes Atlas. 4th ed. (2009), International Diabetes Federation, Brussels
2. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 9 (1998) 1414-1431
3. International Diabetes Federation, The human, social and economic impact of diabetes. Available at: http://www.idf.org/home/index.cfm?node=41. 2008.
4. Egede L.E. Disease-focused or integrated treatment: diabetes and depression. Med. Clin. North Am. 90 4 (2006) 627-646
5. Greden J.F. Physical symptoms of depression: unmet needs. J. Clin. Psychiatry 64 Suppl. 7 (2003) 5-11
6. World Health Organization, Revised global burden of disease (GBD) 2002 estimates. Available from: http://www.who.int/healthinfo/bodgbd2002revised/en/index.html. 2005.
7. Ustun T.B., Ayuso-Mateos J.L., Chatterji S., Mathers C., and Murray C.J. Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 184 (2004) 386-392
8. Lin E.H., Korff M.V., Alonso J., Angermeyer M.C., Anthony J., Bromet E., et al. Mental disorders among persons with diabetes--results from the World Mental Health Surveys. J. Psychosom. Res. 65 6 (2008) 571-580
9. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 23 (2003) 3095-3105
10. Alonso J., Angermeyer M.C., Bernert S., Bruffaerts R., Brugha T.S., Bryson H., et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta. Psychiatr. Scand. Suppl. 420 (2004) 21-27
11. Demyttenaere K., Bruffaerts R., Posada-Villa J., Gasquet I., Kovess V., Lepine J.P., et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 291 21 (2004) 2581-2590
12. Michaud C.M., Murray C.J., and Bloom B.R. Burden of disease-implications for future research. JAMA 285 5 (2001) 535-539
13. US Department of Health and Human Services, Mental health: a report of the surgeon general Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health, 1999.
14. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. Fourth ed. 2000, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
15. Spitzer R.L., Williams J.B., Kroenke K., Linzer M., deGuy F.V.r., Hahn S.R., et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 272 22 (1994) 1749-1756
16. Beck A., Ward C., and Mendelson M. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 53-63
17. Zung W. A self-rating depression scale. Arch. Gen. Psychiatry 12 (1965) 63-70
18. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977) 385-401
19. Whooley M.A., Avins A.L., Miranda J., and Browner W.S. Case-finding instruments for depression. Two questions are as good as many. J. Gen. Intern. Med. 12 (1997) 439-445
20. Kroenke K., Spitzer R.L., and Williams J.B. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 16 9 (2001) 606-613
21. U.S. Preventative Services Task Force (USPSTF). Screening for depression: recommendations and rationale. J. Gen. Intern. Med. 136 10 (2002) 760-764
22. Willis T. Diabetes: A Medical Odyssey (1971), Tuckahoe, New York
23. Anderson R.J., Freedland K.E., Clouse R.E., and Lustman P.J. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24 6 (2001) 1069-1078
24. Li C., Ford E.S., Strine T.W., and Mokdad A.H. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care 31 1 (2008) 105-107
25. Li C., Ford E.S., Zhao G., Ahluwalia I.B., Pearson W.S., and Mokdad A.H. Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the Behavioral Risk Factor Surveillance System. Diabetes Res Clin Pract 83 2 (2009) 268-279
26. Asghar S., Hussain A., Ali S.M., Khan A.K., and Magnusson A. Prevalence of depression and diabetes: a population-based study from rural Bangladesh. Diabet. Med. 24 8 (2007) 872-877
27. Sotiropoulos A., Papazafiropoulou A., Apostolou O., Kokolaki A., Gikas A., and Pappas S. Prevalence of depressive symptoms among non insulin treated Greek type 2 diabetic subjects. BMC Res. Notes 1 (2008) 101
28. Zahid N., Asghar S., Claussen B., and Hussain A. Depression and diabetes in a rural community in Pakistan. Diabetes Res. Clin. Pract. 79 1 (2008) 124-127
29. Khamseh M.E., Baradaran H.R., and Rajabali H. Depression and diabetes in Iranian patients: a comparative study. Int. J. Psychiatry Med. 37 1 (2007) 81-86
30. Almawi W., Tamim H., Al-Sayed N., Arekat M.R., Al-Khateeb G.M., Baqer A., et al. Association of comorbid depression, anxiety, and stress disorders with Type 2 diabetes in Bahrain, a country with a very high prevalence of Type 2 diabetes. J. Endocrinol. Invest. 31 11 (2008) 1020-1024
31. Mier N., Bocanegra-Alonso A., Zhan D., Wang S., Stoltz S.M., Acosta-Gonzalez R.I., et al. Clinical depressive symptoms and diabetes in a binational border population. J. Am. Board Fam. Med. 21 3 (2008) 223-233
32. Kogan S.M., Brody G.H., Crawley C., Logan P., and Murry V.M. Correlates of elevated depressive symptoms among rural African American adults with type 2 diabetes. Ethn. Dis. 17 1 (2007) 106-112
33. Gary T.L., Crum R.M., Cooper-Patrick L., Ford D., and Brancati F.L. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care 23 1 (2000) 23-29
34. Ali S., Stone M.A., Peters J.L., Davies M.J., and Khunti K. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet. Med. 23 11 (2006) 1165-1173
35. Knol M.J., Twisk J.W., Beekman A.T., Heine R.J., Snoek F.J., and Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49 5 (2006) 837-845
36. Mezuk B., Eaton W.W., Albrecht S., and Golden S.H. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31 12 (2008) 2383-2390
37. Golden S.H., Lazo M., Carnethon M., Bertoni A.G., Schreiner P.J., Roux A.V., et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 299 23 (2008) 2751-2759
38. Musselman D.L., Betan E., Larsen H., and Phillips L.S. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol. Psychiatry 54 3 (2003) 317-329
39. Talbot F., and Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link?. Diabetes Care 23 10 (2000) 1556-1562
40. Saydah S.H., Brancati F.L., Golden S.H., Fradkin J., and Harris M.I. Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample. Diabetes Metab. Res. Rev. 19 (2003) 202-208
41. Palinkas L.A., Barrett-Connor E., and Wingard D.L. Type 2 diabetes and depressive symptoms in older adults: a population-based study. Diabet. Med. 8 6 (1991) 532-539
42. Lustman P.J., Anderson R.J., Freedland K.E., de Groot M., Carney R.M., and Clouse R.E. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23 7 (2000) 934-942
43. Richardson L.K., Egede L.E., Mueller M., Echols C.L., and Gebregziabher M. Longitudinal effects of depression on glycemic control in veterans with Type 2 diabetes. Gen. Hosp. Psychiatry 30 6 (2008) 509-514
44. Wagner J.A., Abbott G.L., Heapy A., and Yong L. Depressive symptoms and diabetes control in African Americans. J. Immigr. Minor. Health 11 1 (2009) 66-70
45. Van Tilburg M.A., McCaskill C.C., Lane J.D., Edwards C.L., Bethel A., Feinglos M.N., et al. Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom. Med. 63 4 (2001) 551-555
46. Egede L.E. Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes. Curr. Diabetes Rev. 1 (2005) 235-243
47. Gonzalez .S., Safren S.A., Delahanty L.M., Cagliero E., Wexler D.J., Meigs J.B., et al. Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet. Med. 25 9 (2008) 1102-1107
48. Gonzalez J.S., Peyrot M., McCarl L.A., Collins E.M., Serpa L., Mimiaga M.J., et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 31 12 (2008) 2398-2403
49. Cramer J.A. A systematic review of adherence with medications for diabetes. Diabetes Care 27 5 (2004) 1218-1224
50. Lin E.H., Katon W., Von Korff M., Rutter C., Simon G.E., Oliver M., et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 27 9 (2004) 2154-2160
51. Gonzalez J.S., Safren S.A., Cagliero E., Wexler D.J., Delahanty L., Wittenberg E., et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 30 9 (2007) 2222-2227
52. Egede L.E., and Ellis C. The effects of depression on diabetes knowledge, diabetes self-management, and perceived control in indigent patients with type 2 diabetes. Diabetes Technol. Ther. 10 3 (2008) 213-219
53. de Groot M., Anderson R., Freedland K.E., Clouse R.E., and Lustman P.J. Association of depression and diabetes complications: a meta-analysis. Psychosom. Med. 63 4 (2001) 619-630
54. Clouse R.E., Lustman P.J., Freedland K.E., Griffith L.S., McGill J.B., and Carney R.M. Depression and coronary heart disease in women with diabetes. Psychosom. Med. 65 3 (2003) 376-383
55. Roy M.S., Roy A., and Affouf M. Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes. Psychosom. Med. 69 6 (2007) 537-542
56. Sahota P.K., Knowler W.C., and Looker H.C. Depression, diabetes, and glycemic control in an American Indian community. J. Clin. Psychiatry 69 5 (2008) 800-809
57. Gross R., Olfson M., Gameroff M.J., Carasquillo O., Shea S., Feder A., et al. Depression and glycemic control in Hispanic primary care patients with diabetes. J. Gen. Intern. Med. 20 5 (2005) 460-466
58. Black S.A., Markides K.S., and Ray L.A. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 26 10 (2003) 2822-2828
59. Egede L.E. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 27 2 (2004) 421-428
60. Egede L.E. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care 27 7 (2004) 1751-1753
61. Eren I., Erdi O., and Sahin M. The effect of depression on quality of life of patients with type II diabetes mellitus. Depress. Anxiety 25 2 (2008) 98-106
62. Grandy S., Chapman R.H., and Fox K.M. Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Int. J. Clin. Pract. 62 4 (2008) 562-568
63. Le T.K., Able S.L., and Lage M.J. Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff. Resour. Alloc. 4 (2006) 18
64. Ciechanowski P.S., Katon W.J., and Russo J.E. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch. Intern. Med. 160 21 (2000) 3278-3285
65. Finkelstein E.A., Bray J.W., Chen H., et al. Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 26 2 (2003) 415-420
66. Nichols L., Barton P.L., Glazner J., and McCollum M. Diabetes, minor depression and health care utilization and expenditures: a retrospective database study. Cost Eff. Resour. Alloc. 5 (2007) 4
67. Egede L.E., Zheng D., and Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25 3 (2002) 464-470
68. Zhang X., Norris S.L., Gregg E.W., Cheng Y.J., Beckles G., and Kahn H.S. Depressive symptoms and mortality among persons with and without diabetes. Am. J. Epidemiol. 161 7 (2005) 652-660
69. Katon W., Fan M.Y., Unutzer J., et al. Depression and diabetes: a potentially lethal combination. J. Gen. Intern. Med. 23 10 (2008) 1571-1575
70. Egede L.E., Nietert P.J., and Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 28 6 (2005) 1339-1345
71. Egede L.E. Failure to recognize depression in primary care: issues and challenges. J. Gen. Intern. Med. 22 5 (2007) 701-703
72. Lustman P.J., Griffith L.S., Clouse R.E., Freedland K.E., Eisen S.A., Rubin E.H., et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom. Med. 59 3 (1997) 241-250
73. Lustman P.J., Freedland K.E., Griffith L.S., and Clouse R.E. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23 5 (2000) 618-623
74. Williams Jr. J.W., Katon W., Lin E.H., Noel P.H., Worchel J., Cornell J., et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann. Intern. Med. 140 12 (2004) 1015-1024
75. Wang M.Y., Tsai P.S., Chou K.R., and Chen C.M. A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in type 2 diabetics. J. Clin. Nurs. 17 19 (2008) 2524-2530
76. Lustman P.J., Griffith L.S., Freedland K.E., Kissel S.S., and Clouse R.E. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann. Intern. Med. 129 8 (1998) 613-621
77. Katon W.J., Von Korff M., Lin E.H., Simon G., Ludman E., Russo J., et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch. Gen. Psychiatry 61 10 (2004) 1042-1049
78. Snoek F.J., van der Ven N.C., Twisk J.W., Hogenelst M.H., Tromp-Wever A.M., van der Ploeg H.M., et al. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial. Diabet. Med. 25 11 (2008) 1337-1342
79. Petrak F., and Herpertz S. Treatment of depression in diabetes: an update. Curr. Opin. Psychiatry 22 2 (2009) 211-217
80. Simon G.E., Katon W.J., Lin E.H., et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch. Gen. Psychiatry 64 1 (2007) 65-72
81. Katon W.J., Russo J.E., Von Korff M., Lin E.H., Ludman E., and Ciechanowski P.S. Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes. Diabetes Care 31 6 (2008) 1155-1159
82. Ludman E.J., Katon W., Russo J., Von Korff M., Simon G., Ciechanowski P., et al. Depression and diabetes symptom burden. Gen. Hosp. Psychiatry 26 6 (2004) 430-436
83. Adriaanse M.C., Dekker J.M., Spijkerman A.M., Twisk J.W., Nijpels G., van der Ploeg H.M., et al. Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: the Hoorn Screening Study. Qual. Life Res. 14 6 (2005) 1501-1509
84. Nutting P.A., Rost K., Dickinson M., Werner J.J., Dickinson P., Smith J.L., et al. Barriers to initiating depression treatment in primary care practice. J Gen Intern. Med. 17 2 (2002) 103-111
85. IDF Clinical Guidelines Task Force, Global guideline for Type 2 diabetes. 2005, Brussels: International Diabetes Federation.